摘要
自杀行为是老年人常见的死亡原因,这类人群往往是伴随着身体的残疾和心理障碍。老年人的大脑里常见于与阿尔茨海默病相关的病理改变。虽然有报道阿尔茨海默氏病(AD)可潜在的预测自杀行为,但没有系统地探讨自杀行为和AD之间的关系。本文的目的是回顾目前的关于自杀风险和AD之间关系的文献,以确定自杀的最相关的风险和保护因素。全面搜索1980年1月到2015年8月间PubMed, Scopus,PsycINFO,Science Direct杂志关于对自杀行为和AD的文献。搜索出164篇文章,其中21篇符合我们的纳入标准。八篇横向研究,两篇纵向研究,三篇回顾性研究,八例(11个患者)病例报告调查了自杀风险和AD的关系。诊断为痴呆的AD甚至许多年后出现自杀情况,曾试图自杀过一次的患者有死于自杀的更高风险。AD与自杀的中度风险相关,治疗AD患者的临床医生应对他们的自杀风险进行适当的评估。然而,需要更多的前瞻性研究来阐明AD和自杀风险之间的关联。
关键词: 阿尔茨海默病,病理改变,自杀行为,自杀意念,老年人。
Current Alzheimer Research
Title:Suicide Risk in Alzheimer’s Disease: A Systematic Review
Volume: 13 Issue: 10
Author(s): Gianluca Serafini, Pietro Calcagno, David Lester, Paolo Girardi, Mario Amore, Maurizio Pompili
Affiliation:
关键词: 阿尔茨海默病,病理改变,自杀行为,自杀意念,老年人。
摘要: Suicidal behavior is a common cause of death in the elderly and is often accompanied in this population by disabilities and psychosocial impairment. Alzheimer’s-related neuropathological changes are commonly found in the brains of older people. Although Alzheimer’s disease (AD) has been reported to be a potential predictor for suicidal behavior, the relationship between suicidal behavior and AD has not been systematically explored. The aim of this paper is to review the current literature regarding the association between suicide risk and AD in an effort to identify the most relevant risk and protective factors for suicide. A detailed strategy was used to search for relevant articles in Pubmed, Scopus, PsycINFO, and Science Direct on suicidal behavior and AD for the period of January 1980 to August 2015. The search yielded 164 articles, of which 21 met our inclusion criteria. Eight crosssectional, two longitudinal, 3 retrospective, and eight case reports (of 11 patients) examined the association between suicide risk and AD. Suicide occurs in AD even many years after the diagnosis of dementia, and patients who have attempted suicide once are at a higher risk of dying from suicide. AD is associated with a moderate risk of suicide, and clinicians working with AD patients should undertake an appropriate assessment of their suicidal risk. However, more prospective studies are needed to clarify the association between AD and suicide risk.
Export Options
About this article
Cite this article as:
Gianluca Serafini, Pietro Calcagno, David Lester, Paolo Girardi, Mario Amore, Maurizio Pompili , Suicide Risk in Alzheimer’s Disease: A Systematic Review, Current Alzheimer Research 2016; 13 (10) . https://dx.doi.org/10.2174/1567205013666160720112608
DOI https://dx.doi.org/10.2174/1567205013666160720112608 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Products as a Source of CNS-Active Agents
Mini-Reviews in Organic Chemistry MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14
Current Neurovascular Research Analysis of the Applicability and Use of Lipinski`s Rule for Central Nervous System Drugs
Letters in Drug Design & Discovery Neurodegeneration and Neuroprotective Agents in Multiple Sclerosis
Recent Patents on CNS Drug Discovery (Discontinued) Miglustat: Substrate Reduction Therapy for Lysosomal Storage Disorders Associated with Primary Central Nervous System Involvement
Recent Patents on CNS Drug Discovery (Discontinued) D-Galactose as a Vector for Prodrug Design
Current Topics in Medicinal Chemistry Botulinum A Toxin Intravesical Injections for Painful Bladder Syndrome: Impact Upon Pain, Psychological Functioning and Quality of Life
Current Drug Delivery Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity
Current Medicinal Chemistry Microglial Activation and its Implications in the Brain Diseases
Current Medicinal Chemistry Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease
Current Neuropharmacology DL-3-n-Butylphthalide, an Anti-Oxidant Agent, Prevents Neurological Deficits and Cerebral Injury Following Stroke per Functional Analysis, Magnetic Resonance Imaging and Histological Assessment
Current Neurovascular Research Oxidative Stress and Drugs of Abuse: An Update
Mini-Reviews in Organic Chemistry A synopsis on the linkage between age-related dementias and vascular disorders
CNS & Neurological Disorders - Drug Targets Nose to Brain Delivery: New Trends in Amphiphile-Based “Soft” Nanocarriers
Current Pharmaceutical Design Stress and Brain Atrophy
CNS & Neurological Disorders - Drug Targets Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design
Current Drug Metabolism Present Perspectives on the Automated Classification of the G-Protein Coupled Receptors (GPCRs) at the Protein Sequence Level
Current Topics in Medicinal Chemistry Depressed or Demented: Common CNS Drug Targets? !
Current Drug Targets - CNS & Neurological Disorders